AQR Arbitrage’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

AQR Arbitrage’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-172,892	Closed	-$1.72M	–	1475
2022 Q3	$1.72M	Hold	172,892	–	–	0.04%	514
2022 Q2	$1.71M	Hold	172,892	–	–	0.04%	485
2022 Q1	$1.7M	Buy	172,892 +150,000	+655%	+$1.47M	0.04%	408
2021 Q4	$223K	Hold	22,892	–	–	0.01%	1101
2021 Q3	$223K	Sell	22,892 -2,108	-8%	-$20.6K	0.01%	728
2021 Q2	$244K	Hold	25,000	–	–	0.01%	742
2021 Q1	$249K	Buy	+25,000	New	+$255K	0.01%	739

AQR Arbitrage's FLAC Position: Q4 2022 in Review

AQR Arbitrage sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 172,892 shares — an estimated $1.72M sold.

AQR Arbitrage first reported a position in FLAC in Q1 2021 and held it in 7 quarters. The position peaked at $1.72M in Q3 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

AQR Arbitrage reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
AQR Arbitrage sold 172,892 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $1.72M.
AQR Arbitrage first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q1 2021 and held it in 7 quarters.
AQR Arbitrage's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $1.72M in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on AQR Arbitrage's 13F filing for Q4 2022, filed 14 Feb 2023.